BC
EDIT icon

BIT Capital’s Editas Medicine EDIT Stock Holding History

BIT Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
+326,000
New +$953K 0.03% 77

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

BIT Capital's EDIT Position: Q2 2026 in Review

BIT Capital opened a new position in Editas Medicine (EDIT) in Q2 2026: 326,000 shares worth $1.06M. The stake represents 0.03% of the portfolio and ranks #77 among its holdings.

124 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • BIT Capital held 326,000 shares of Editas Medicine worth $1.06M as of Q2 2026.
  • Editas Medicine was a new BIT Capital position in Q2 2026.
  • Editas Medicine made up 0.03% of BIT Capital's portfolio in Q2 2026, its #77 holding.
  • 124 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on BIT Capital's 13F filing for Q2 2026, filed 12 Aug 2026.